Literature DB >> 21187089

Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells.

Hyung Gyun Kim1, Jin Young Kim, Eun Hee Han, Yong Pil Hwang, Jae Ho Choi, Bong Hwan Park, Hye Gwang Jeong.   

Abstract

The overexpression of metallothionein-2A (MT-2A) is frequently observed in invasive human breast tumors and has been linked with more aggressive breast cancers. MT-2A overexpression led to the induction of MDA-MB-231 breast cancer cell migratory and invasive abilities. The reduction of MT-2A expression through small interfering RNA (siRNA) targeting MT-2A in invasive MDA-MB-231 cells completely inhibited both cell invasion and migration. In addition, the expression of matrix metalloproteinase-9 (MMP-9) and the transcriptional activity of AP-1 and NF-κB were upregulated by MT-2A overexpression. Collectively, our results provide the first demonstration that MT-2A promotes breast cancer cell invasion by upregulating MMP-9 via AP-1 and NF-κB activation. Furthermore, we found that MT-2A silencing can inhibit breast cancer invasiveness.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187089     DOI: 10.1016/j.febslet.2010.12.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

1.  Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines.

Authors:  Tatjana Sauerer; Christopher Lischer; Adrian Weich; Carola Berking; Julio Vera; Jan Dörrie
Journal:  Front Microbiol       Date:  2021-12-22       Impact factor: 5.640

2.  A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium.

Authors:  Sabreena Safuan; Sarah J Storr; Poulam M Patel; Stewart G Martin
Journal:  Lymphat Res Biol       Date:  2012-12-05       Impact factor: 2.589

3.  Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc.

Authors:  Scott V Adams; Brian Barrick; Emily P Christopher; Martin M Shafer; Karen W Makar; Xiaoling Song; Johanna W Lampe; Hugo Vilchis; April Ulery; Polly A Newcomb
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-31       Impact factor: 4.219

4.  Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.

Authors:  Hana Polanska; Zbynek Heger; Jaromir Gumulec; Martina Raudenska; Marketa Svobodova; Jan Balvan; Michaela Fojtu; Hana Binkova; Zuzana Horakova; Rom Kostrica; Vojtech Adam; Rene Kizek; Michal Masarik
Journal:  Tumour Biol       Date:  2015-12-14

5.  Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression.

Authors:  Alicja M Kmiecik; Bartosz Pula; Jaroslaw Suchanski; Mateusz Olbromski; Agnieszka Gomulkiewicz; Tomasz Owczarek; Anna Kruczak; Aleksandra Ambicka; Janusz Rys; Maciej Ugorski; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

6.  Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer.

Authors:  Anna Krześlak; Ewa Forma; Paweł Jóźwiak; Agnieszka Szymczyk; Beata Smolarz; Hanna Romanowicz-Makowska; Waldemar Różański; Magdalena Bryś
Journal:  Clin Exp Med       Date:  2012-10-06       Impact factor: 3.984

7.  A dynamic time order network for time-series gene expression data analysis.

Authors:  Pengyue Zhang; Raphaël Mourad; Yang Xiang; Kun Huang; Tim Huang; Kenneth Nephew; Yunlong Liu; Lang Li
Journal:  BMC Syst Biol       Date:  2012-12-17

8.  Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data.

Authors:  Miriam Ragle Aure; Israel Steinfeld; Lars Oliver Baumbusch; Knut Liestøl; Doron Lipson; Sandra Nyberg; Bjørn Naume; Kristine Kleivi Sahlberg; Vessela N Kristensen; Anne-Lise Børresen-Dale; Ole Christian Lingjærde; Zohar Yakhini
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection.

Authors:  Yuanming Pan; Jiaqiang Huang; Rui Xing; Xin Yin; Jiantao Cui; Wenmei Li; Jun Yu; Youyong Lu
Journal:  J Transl Med       Date:  2013-07-19       Impact factor: 5.531

10.  MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.

Authors:  Xiaofeng Chen; Jinrong Qiu; Dapeng Yang; Jianlei Lu; Caiyun Yan; Xiaoming Zha; Yongmei Yin
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.